NCT04560621Completed
Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers
Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers: A Stepped Wedge Hybrid Type II Effectiveness Implementation Trial
Source: ClinicalTrials.gov · Last updated 3 Jul 2025
Brief summary (registry, in English)
The Managed Problem Solving (MAPS) behavioral intervention is an EBP for behavior change in people living with HIV (PLWH). The investigators propose that MAPS can be delivered by trained Community Health Workers (CHWs). The use of CHWs to deliver MAPS is justified by their ability to develop trusting relationships with their clients and the need for task shifting in busy clinics. In order to also address retention in care, the investigators will adapt MAPS to also focus on problem solving activities tailored toward retention in care (now termed MAPS+). CHWs will be located in clinics to implement MAPS+ to improve viral suppression and care retention in PLWH. Data-to-care allows for identification of people who are lost to care and link these patients back to care. Currently, medication adherence and retention in HIV care are not targeted in data-to-care so the investigators will build on this approach to facilitate the identification of PLWH who are out of care and not virally suppressed to offer them MAPS+. The set of implementation strategies include task-shifting the delivery of MAPS+ to CHWs, providing the CHWs training and ongoing support, and increasing communication between the CHWs and medical care team via standardized protocols. The investigators will conduct a hybrid type II effectiveness-implementation trial with a stepped-wedge cluster randomized design in 12 clinics to test MAPS+ compared to usual care using a set of implementation strategies that will best support implementation. Each clinic will be randomized to one of three implementation start times. Baseline (usual care) data will be collected from each clinic for 6 months, followed by MAPS+ and the package of implementation strategies for 12 months, in three cohorts of 4 clinics each. Aim 1 will test the effectiveness of MAPS+ on clinical effectiveness outcomes, including viral suppression (primary) and retention (secondary). Aim 2 will examine the effect of the package of implementation strategies on reach. Implementation cost will also be measured. Aim 3 will apply a qualitative approach to understand processes, mechanisms, and sustainment of the implementation approach. The results will guide future efforts to implement behavioral EBPs across the HIV care continuum, consistent with the "treat" pillar of EHE, and move the science of implementation services, consistent with NIH strategic priorities.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 210 (actual)
- First submitted
- 17 Sept 2020
- Start date
- 1 Feb 2022
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- University of Pennsylvania
- Diseases
- HIV
- NCT number
- NCT04560621
What you commit to
- Study type: Interventional
- Participants enrolled: 210
- From 1 Feb 2022 to the primary completion date, 30 Jun 2025
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- incarcerated during the duration of the trial
Who the study is looking for
- age 18 or older
- a man or woman living with HIV
- not retained in care and/or virally suppressed in year prior to trial initiation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cooper Early Intervention Program and Infectious Diseases Coordinator of this site? Confirm its status | Camden | United States | Unknown status |
| PHMC Care Clinic Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| Jefferson HIV Ambulatory Care Program Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| Einstein Immunodeficiency Center Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| Mazzoni Center Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| The Drexel Partnership Comprehensive Care Practice Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| MacGregor Infectious Diseases Clinic at the University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| Philadelphia FIGHT Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| Penn Presbyterian Medical Center Infectious Diseases Specialty Clinic at the University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| Temple Comprehensive HIV Program Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.